Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy, highlights key policy updates that are impacting managed care pharmacy.

In an interview with Adam Colborn, JD, director of government relations for the Academy of Managed Care Pharmacy focuses on biosimilar interchangeability and approaches to encourage wider adoption in ...

as shown in 2 retrospective studies presented at the Academy of Managed Care Pharmacy annual meeting (AMCP 2025). The top 5 biosimilar conference articles in 2024 highlight significant progress in the ...

The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting factors.

In the Monte Carlo simulation, the mean ± S.D. net benefit expected from a pharmacy-managed medication assistance program was $102,767 ± $47,560 (Figure 1). The median net benefit was $94,320 ...

Law firms’ approaches to storing and managing e-discovery data have evolved dramatically, progressing from manual, paper-based processes to sophisticated, technology-driven solutions. In the ...

A new Academy of Managed Care Pharmacy Foundation report, “Emerging Trends Impacting Managed Care Pharmacy,” developed in partnership with Pfizer, warned of significant shifts within managed ...

The American Academy of Dermatology is committed to providing the public with science-based information to help them make informed decisions about their skin, hair and nail health. Research on this ...